vs
CareDx, Inc.（CDNA）与MP Materials Corp.（MP）财务数据对比。点击上方公司名可切换其他公司
CareDx, Inc.的季度营收约是MP Materials Corp.的1.3倍（$117.7M vs $90.6M），CareDx, Inc.净利率更高（2.4% vs -8.8%，领先11.2%），MP Materials Corp.同比增速更快（49.1% vs 39.0%），过去两年MP Materials Corp.的营收复合增速更高（70.3% vs 12.9%）
CareDx是一家专注于器官移植领域的精准医疗企业，核心产品包括移植排斥反应监测诊断试剂、数字健康管理工具及配套临床服务，面向北美和欧洲市场的医疗机构及移植患者，助力提升术后患者生存质量。
MP Materials Corp.是总部位于美国的稀土材料生产商，拥有并运营加利福尼亚州芒廷帕斯矿，这是西半球唯一在产的稀土开采及加工设施，所产核心材料可广泛应用于电动汽车、风力发电机、国防工业等多个关键领域。
CDNA vs MP — 直观对比
营收规模更大
CDNA
是对方的1.3倍
$90.6M
营收增速更快
MP
高出10.1%
39.0%
净利率更高
CDNA
高出11.2%
-8.8%
两年增速更快
MP
近两年复合增速
12.9%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $117.7M | $90.6M |
| 净利润 | $2.8M | $-8.0M |
| 毛利率 | — | — |
| 营业利润率 | 1.0% | — |
| 净利率 | 2.4% | -8.8% |
| 营收同比 | 39.0% | 49.1% |
| 净利润同比 | — | 64.8% |
| 每股收益（稀释后） | $0.05 | $-0.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CDNAMP
| Q1 26 | $117.7M | $90.6M | ||
| Q4 25 | $108.4M | $52.7M | ||
| Q3 25 | $100.1M | $53.6M | ||
| Q2 25 | $86.7M | $57.4M | ||
| Q1 25 | $84.7M | $60.8M | ||
| Q4 24 | $86.6M | $61.0M | ||
| Q3 24 | $82.9M | $62.9M | ||
| Q2 24 | $92.3M | $31.3M |
净利润CDNAMP
| Q1 26 | $2.8M | $-8.0M | ||
| Q4 25 | $-4.1M | $9.4M | ||
| Q3 25 | $1.7M | $-41.8M | ||
| Q2 25 | $-8.6M | $-30.9M | ||
| Q1 25 | $-10.4M | $-22.6M | ||
| Q4 24 | $87.7M | $-22.3M | ||
| Q3 24 | $-10.6M | $-25.5M | ||
| Q2 24 | $-4.6M | $-34.1M |
营业利润率CDNAMP
| Q1 26 | 1.0% | — | ||
| Q4 25 | -5.6% | -7.0% | ||
| Q3 25 | -0.2% | -125.2% | ||
| Q2 25 | -12.8% | -76.5% | ||
| Q1 25 | -15.8% | -57.2% | ||
| Q4 24 | 97.5% | -72.1% | ||
| Q3 24 | -16.6% | -62.8% | ||
| Q2 24 | -7.9% | -171.1% |
净利率CDNAMP
| Q1 26 | 2.4% | -8.8% | ||
| Q4 25 | -3.8% | 17.9% | ||
| Q3 25 | 1.7% | -78.0% | ||
| Q2 25 | -9.9% | -53.8% | ||
| Q1 25 | -12.2% | -37.2% | ||
| Q4 24 | 101.3% | -36.6% | ||
| Q3 24 | -12.8% | -40.5% | ||
| Q2 24 | -5.0% | -108.9% |
每股收益（稀释后）CDNAMP
| Q1 26 | $0.05 | $-0.04 | ||
| Q4 25 | $-0.08 | $0.07 | ||
| Q3 25 | $0.03 | $-0.24 | ||
| Q2 25 | $-0.16 | $-0.19 | ||
| Q1 25 | $-0.19 | $-0.14 | ||
| Q4 24 | $1.60 | $-0.12 | ||
| Q3 24 | $-0.20 | $-0.16 | ||
| Q2 24 | $-0.09 | $-0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $77.9M | $1.7B |
| 总债务越低越好 | — | $1.0B |
| 股东权益账面价值 | — | $2.0B |
| 总资产 | $411.1M | $3.8B |
| 负债/权益比越低杠杆越低 | — | 0.51× |
8季度趋势，按日历期对齐
现金及短期投资CDNAMP
| Q1 26 | $77.9M | $1.7B | ||
| Q4 25 | $177.2M | $1.2B | ||
| Q3 25 | $194.2M | $1.1B | ||
| Q2 25 | $186.3M | $261.5M | ||
| Q1 25 | $230.9M | $198.3M | ||
| Q4 24 | $260.7M | $282.4M | ||
| Q3 24 | $240.9M | $284.4M | ||
| Q2 24 | $228.9M | $295.6M |
总债务CDNAMP
| Q1 26 | — | $1.0B | ||
| Q4 25 | — | $998.7M | ||
| Q3 25 | — | $997.3M | ||
| Q2 25 | — | $910.8M | ||
| Q1 25 | — | $909.8M | ||
| Q4 24 | — | $908.7M | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $0 | — |
股东权益CDNAMP
| Q1 26 | — | $2.0B | ||
| Q4 25 | $303.1M | $2.0B | ||
| Q3 25 | $311.1M | $2.0B | ||
| Q2 25 | $327.4M | $1.0B | ||
| Q1 25 | $379.3M | $1.0B | ||
| Q4 24 | $378.4M | $1.1B | ||
| Q3 24 | $273.2M | $1.1B | ||
| Q2 24 | $264.7M | $1.1B |
总资产CDNAMP
| Q1 26 | $411.1M | $3.8B | ||
| Q4 25 | $413.2M | $3.9B | ||
| Q3 25 | $432.3M | $3.8B | ||
| Q2 25 | $444.3M | $2.3B | ||
| Q1 25 | $489.6M | $2.4B | ||
| Q4 24 | $491.1M | $2.3B | ||
| Q3 24 | $477.0M | $2.3B | ||
| Q2 24 | $466.8M | $2.4B |
负债/权益比CDNAMP
| Q1 26 | — | 0.51× | ||
| Q4 25 | — | 0.50× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | 0.88× | ||
| Q4 24 | — | 0.86× | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.3M | $-1.9M |
| 自由现金流经营现金流 - 资本支出 | $514.0K | — |
| 自由现金流率自由现金流/营收 | 0.4% | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.54× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CDNAMP
| Q1 26 | $4.3M | $-1.9M | ||
| Q4 25 | $21.4M | $-46.9M | ||
| Q3 25 | $37.4M | $-42.0M | ||
| Q2 25 | $9.9M | $-3.7M | ||
| Q1 25 | $-26.6M | $-63.2M | ||
| Q4 24 | $21.9M | $30.5M | ||
| Q3 24 | $12.5M | $-6.8M | ||
| Q2 24 | $18.9M | $30.8M |
自由现金流CDNAMP
| Q1 26 | $514.0K | — | ||
| Q4 25 | — | $-109.3M | ||
| Q3 25 | — | $-92.5M | ||
| Q2 25 | — | $-32.7M | ||
| Q1 25 | — | $-93.7M | ||
| Q4 24 | — | $-11.2M | ||
| Q3 24 | — | $-53.3M | ||
| Q2 24 | — | $-15.6M |
自由现金流率CDNAMP
| Q1 26 | 0.4% | — | ||
| Q4 25 | — | -207.4% | ||
| Q3 25 | — | -172.8% | ||
| Q2 25 | — | -56.9% | ||
| Q1 25 | — | -154.0% | ||
| Q4 24 | — | -18.3% | ||
| Q3 24 | — | -84.7% | ||
| Q2 24 | — | -50.1% |
资本支出强度CDNAMP
| Q1 26 | — | — | ||
| Q4 25 | — | 118.5% | ||
| Q3 25 | — | 94.3% | ||
| Q2 25 | — | 50.5% | ||
| Q1 25 | — | 50.1% | ||
| Q4 24 | — | 68.3% | ||
| Q3 24 | — | 73.8% | ||
| Q2 24 | — | 148.7% |
现金转化率CDNAMP
| Q1 26 | 1.54× | — | ||
| Q4 25 | — | -4.97× | ||
| Q3 25 | 22.30× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.25× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CDNA
| Financial Results Total | $85.0M | 72% |
| Patient and digital solutions revenue | $16.0M | 14% |
| Product revenue | $10.3M | 9% |
| Other | $6.4M | 5% |
MP
| Materials Segment | $72.2M | 80% |
| Magnetics Segment | $21.1M | 23% |
